Amparo Sánchez-Gastaldo

First-line nivolumab plus ipilimumab for metastatic non-small cell lung cancer, including patients with ECOG performance status 2 and other special populations: CheckMate 817

Neal Ready, Clarisse Audigier-Valette, Jonathan W. Goldman et al. · Journal for ImmunoTherapy of Cancer · 2023 · 73 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Identification of Oxidative Stress Related Proteins as Biomarkers for Lung Cancer and Chronic Obstructive Pulmonary Disease in Bronchoalveolar Lavage

María Dolores Pastor, Ana Nogal, Sonia Molina‐Pinelo et al. · International Journal of Molecular Sciences · 2013 · 39 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Correlation of peripheral blood biomarkers with clinical outcomes in NSCLC patients with high PD-L1 expression treated with pembrolizumab

Amparo Sánchez-Gastaldo, Miguel A. Muñoz-Fuentes, Sonia Molina‐Pinelo et al. · Translational Lung Cancer Research · 2021 · 38 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Prognostic Value of Clinical Staging According to TNM in Patients With SCLC: A Real-World Surveillance Epidemiology and End-Results Database Analysis

Edurne Arriola, José Trigo, Amparo Sánchez-Gastaldo et al. · JTO Clinical and Research Reports · 2021 · 32 citations · Full text

Medicine, Clinical Sciences, Oncology +16

SEOM Clinical guidelines for the treatment of advanced colorectal cancer 2013

Enrique Casado-Sáenz, Jaime Feliú, María Auxiliadora Gómez‐España et al. · Clinical & Translational Oncology · 2013 · 24 citations

Medicine, Oncology, Surgery +14